Transdermal buprenorphine for moderate chronic noncancer pain syndromes

Disproportionality analysis of buprenorphine transdermal system and cardiac arrhythmia using FDA and WHO postmarketing reporting system data

(2017) Nelson E. Sessler et al.   POSTGRADUATE MEDICINE

Efficacy and Safety of Transdermal Buprenorphine versus Oral Tramadol/Acetaminophen in Patients with Persistent Postoperative Pain after Spinal Surgery

(2017) Jae Hyup Lee et al.   Pain Research & Management

Transdermal Buprenorphine Relieves Neuropathic Pain: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial in Diabetic Peripheral Neuropathic Pain

(2016) Richard W. Simpson et al.   DIABETES CARE

Naloxegol (Movantik) for Opioid-Induced Constipation

(2016)   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Dose-Dependent Flux of Buprenorphine Following Transdermal Administration in Healthy Subjects

(2016) Yi Wang et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Comparison of abuse, suspected suicidal intent, and fatalities related to the 7-day buprenorphine transdermal patch versus other opioid analgesics in the National Poison Data System

(2016) Paul M Coplan et al.   POSTGRADUATE MEDICINE

Estimates of Pain Prevalence and Severity in Adults: United States, 2012

(2015) Richard L. Nahin   JOURNAL OF PAIN

Interpretation of Urine Drug Testing Results in Patients Using Transdermal Buprenorphine Preparations for the Treatment of Chronic Noncancer Pain: Table 1

(2015) John D. Markman et al.   PAIN MEDICINE

Buprenorphine Transdermal System Improves Sleep Quality and Reduces Sleep Disturbance in Patients with Moderate-to-Severe Chronic Low Back Pain: Results from Two Randomized Controlled Trials

(2015) Aaron Yarlas et al.   Pain Practice

The unsolved case of “bone-impairing analgesics”: the endocrine effects of opioids on bone metabolism

(2015) Flaminia Coluzzi et al.   Therapeutics and Clinical Risk Management

The clinical analgesic efficacy of buprenorphine

(2014) R. B. Raffa et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Mechanisms of Drug-induced Liver Injury

(2013) Liyun Yuan et al.   Clinics in Liver Disease

Low-dose 7-day transdermal buprenorphine in daily clinical practice – perceptions of elderly patients with moderate non-malignant chronic pain

(2012) Michael A. Überall et al.   CURRENT MEDICAL RESEARCH AND OPINION

Pharmacokinetics of transdermal buprenorphine patch in the elderly

(2012) Nabil Al-Tawil et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Once-Weekly Transdermal Buprenorphine Application Results in Sustained and Consistent Steady-State Plasma Levels

(2012) Ram P. Kapil et al.   JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

Efficacy and Safety of Buprenorphine Transdermal System (BTDS) for Chronic Moderate to Severe Low Back Pain: A Randomized, Double-Blind Study

(2011) Deborah Steiner et al.   JOURNAL OF PAIN

Efficacy and Safety of the Seven-Day Buprenorphine Transdermal System in Opioid-Naïve Patients with Moderate to Severe Chronic Low Back Pain: An Enriched, Randomized, Double-Blind, Placebo-Controlled Study

(2011) Deborah J. Steiner et al.   JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

Transdermal buprenorphine plus oral paracetamol vs an oral codeine-paracetamol combination for osteoarthritis of hip and/or knee: a randomised trial

(2011) P.G. Conaghan et al.   OSTEOARTHRITIS AND CARTILAGE

Transdermal Buprenorphine in Non-Oncological Moderate-to-Severe Chronic Pain

(2010) Antonio Gatti et al.   CLINICAL DRUG INVESTIGATION

Buprenorphine transdermal system in adults with chronic low back pain: A randomized, double-blind, placebo-controlled crossover study, followed by an open-label extension phase

(2010) Allan Gordon et al.   CLINICAL THERAPEUTICS

A Randomized, Double-Blind, Double-Dummy Comparison of the Efficacy and Tolerability of Low-Dose Transdermal Buprenorphine (BuTrans® Seven-Day Patches) With Buprenorphine Sublingual Tablets (Temgesic®) in Patients With Osteoarthritis Pain

(2010) Ian G.V. James et al.   JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

Transdermal Buprenorphine for the Treatment of Chronic Noncancer Pain in the Oldest Old

(2010) Walter Gianni et al.   JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

Current Knowledge of Buprenorphine and Its Unique Pharmacological Profile

(2010) Joseph Pergolizzi et al.   Pain Practice

Buprenorphine for Neuropathic Pain—Targeting Hyperalgesia

(2009) Raghava R. Induru et al.   American Journal of Hospice & Palliative Medicine

Efficacy and safety of low-dose transdermal buprenorphine patches (5, 10, and 20 μg/h) versus prolonged-release tramadol tablets (75, 100, 150, and 200 mg) in patients with chronic osteoarthritis pain: A 12-week, randomized, open-label, controlled, parallel-group noninferiority study

(2009) Mats Karlsson et al.   CLINICAL THERAPEUTICS

Clinical update on the pharmacology, efficacy and safety of transdermal buprenorphine

(2008) Hans G. Kress   EUROPEAN JOURNAL OF PAIN

Opioids and the Management of Chronic Severe Pain in the Elderly: Consensus Statement of an International Expert Panel with Focus on the Six Clinically Most Often Used World Health Organization step III Opioids (Buprenorphine, Fentanyl, Hydromorphone, Methadone, Morphine, Oxycodone)

(2008) Joseph Pergolizzi et al.   Pain Practice

Hypogonadism in men receiving methadone and buprenorphine maintenance treatment

(2007) R. Hallinan et al.   INTERNATIONAL JOURNAL OF ANDROLOGY